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Abstract: The utilization of N-glycan profiling recently gained high importance in 
fundamental biomedical and applied clinical research. However, for the time being, no 
glycan biomarker has been approved for clinical diagnosis by the regulatory agencies 
due to the lack of verifications on large patient cohorts and suitable analytical 
technologies. In this paper, the effect of human blood sample handling was studied prior 
to N-glycosylation profiling by capillary electrophoresis, coupled with high sensitivity 
fluorescence detection. Special attention was paid to the preservation of sialylated 
structures because of their important clinical - biological relevance. Our results 
suggested that it is adequate to refrigerate and store the collected total blood samples 
prior to analysis to obtain unbiased results. Furthermore, we report on the good practice 
of serum sample handling in order to prevent decomposition of the sialylated structures. 
Our findings may promote procedure standardization and easier clinical translation of 
diagnostic N-glycosylation profiling in molecular medicinal applications. 
Keywords: Blood sampling, storage temperature, storage time, preanalytical processing, N-glycome, capillary 
electrophoresis. 
1. INTRODUCTION 
 Solid evidence has been reported in the literature 
that the N-glycosylation of blood-born glycoproteins 
may be altered by various diseases [1, 2]. Thus, 
utilization of N-glycan profiling from liquid biopsy 
samples, such as blood, for diagnostic purposes 
gained high importance both in fundamental biomedical 
and applied clinical research. Asparagine linked 
glycosylation is reportedly affected by various 
diseases, resulting in aberrant glycosylation on most 
glycoproteins in human blood [1]. A comprehensive 
analysis of these changes can be utilized for diagnostic 
purposes.  
 Carbohydrates are among the most structurally 
diverse species in nature and are usually analyzed by 
high-performance liquid chromatography (HPLC), 
capillary electrophoresis (CE), mass spectrometry (MS) 
or the hyphenation of those, such as LC-MS or CE-MS 
[3]. One of the most studied subsets of aberrant 
glycosylation vs disease state is cancer [4] in spite of 
the fact that for the time being, none of the potential 
glycan biomarkers have been approved for clinical  
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diagnosis by the regulatory agencies [5]. Successful 
clinical translation is restrained by the lack of 
verifications on large patient cohorts and suitable fast, 
efficient and high throughput analytical technologies. In 
addition, albeit the methods used for analytical 
glycomics are well developed, their integration into 
complete analytical workflows is still in progress. 
 Multiple factors should be considered during 
method development and validation to achieve good 
analytical efficiency, resolution, accuracy, high 
throughput, and robustness. Individual variability of the 
N-glycome regarding sample collection time and 
condition (e.g., storage temperature) as well as factors 
during sample preparation are of high importance. 
Details in analytical processes and standardization of 
data evaluation are all very important too. In an earlier 
study, a great variability of individual glycan profiles 
was observed in a population of 1008 volunteers [6]. 
This demonstrated the need for appropriate sample 
preparation protocols and the standardization of 
adequate glycoanalytical tools for carbohydrate profile 
and composition analysis. For example, the N-glycan 
composition of blood samples is subject to change due 
to the presence of enzymes, even the ones that do not 
require ATP for their action [7-11]. Enzyme activity can 
be affected by a variety of factors, such as 
temperature, pH, and concentration of substrates, just 
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to mention a few [12]. While the importance of sample 
handling and preservation have been reported for 
blood-based proteomics [13-15] and metabolomics [16, 
17] studies, similar evaluation is greatly needed for 
glycomics. Dedova et al. published a pioneering paper 
on the effect of pre-analytical conditions on single 
glycan structure determination as well as on glycan-
based ovarian cancer biomarker GLYCOV scoring [18]. 
The authors investigated the effect of storage 
temperature and processing time on the glycan profiles 
of 10 healthy volunteers after desialylation. However, it 
is important to note that sialylated structures often hold 
important biological information [2], which are lost if the 
samples are desialylated. Ventham and coworkers 
studied the effect of different sample tubes and 
processing methods on whole serum N-glycan profiles 
and found that the investigated factors caused minimal 
inter-individual variations [19]. Cadamuro et al. came to 
the same conclusion, namely that the centrifugation 
conditions did not alter the analyte composition tested 
in their study [20]. Interestingly, even otherwise easily 
overlooked parameters such as the sample volume 
should be considered when assessing the hydration 
status of human blood [21]. 
 One of the most important aspects of any clinical 
laboratory analysis is the choice of biospecimen 
processing, i.e., preparation of samples (e.g., blood) 
after collection. Whole blood, serum, plasma, buffy 
coat, and peripheral blood mononuclear cells are the 
common options to be considered as well as the 
subsequent pre-analytical processing methods and 
conditions including centrifugation, storage 
temperature, process duration, etc. [22]. For global N-
glycosylation profile analysis, human serum is suitable 
because it can be analyzed without the interference of 
insoluble fibrin aggregates or cross-contamination from 
anticoagulants [23]. 
 In this work, the effect of human blood sample 
handling was studied prior to N-glycosylation profiling 
by capillary electrophoresis, coupled with high 
sensitivity fluorescence detection. Special attention 
was paid to the preservation of sialylated structures 
because of their important clinical – biological 
relevance. 
2. MATERIALS AND METHODS 
2.1. Chemicals and Reagents 
 Water (HPLC grade), acetonitrile, sodium 
cyanoborohydride (1 M in THF), glycerol, ammonium 
acetate and DTT (dithiothreitol) were obtained from 
Sigma Aldrich (St. Louis, MO, USA). SDS (sodium 
dodecyl sulfate) and Nonidet P-40 were from VWR 
(Radnor, PA, USA). The Fast Glycan Labeling and 
Analysis Kit was from SCIEX (Brea, CA, USA), 
including the 8-aminopyrene-1,3,6-trisulfonic acid 
(APTS) labeling reagent, the bracketing standard 
(containing maltose, DP2 and maltopentadecaose, 
DP15) and the magnetic beads. The endoglycosidase 
PNGase F was from Asparia Glycomics (San 
Sebastian, Spain). EDTA was from Alfa Aesar (Ward 
Hill, MA, USA).  
2.2. Specimen Collection and Sample Preparation 
 Capillary blood samples were collected from a 
healthy female (ethical approval UD 5570-1/2018/EKU, 
and informed patient consent). Each sample was taken 
simultaneously in the morning using blood lancets 
(Vitrex Medical, Herlev, Denmark). 1.2 µl of 3.19 mM 
EDTA anticoagulant was added to 2 µl collected total 
blood sample and diluted by adding 96.8 µl HPLC 
water in 200 µL vial. The collected total blood samples 
were processed in five main steps: denaturation, 
digestion, glycan release, fluorophore labeling and 
magnetic bead mediated cleanup. Six samples were 
kept at room temperature for 0, 60, 120, 180, 240 and 
300 minutes and then refrigerated at 4 °C for 24 hours. 
Another six samples were kept at room temperature for 
0, 60, 120, 180, 240 and 300 minutes and then 
immediately diluted with HPLC grade water to 97 µL for 
further processing. 
 Prior to N-glycan release, the samples were 
denatured at 80 °C for 10 minutes in a heating block. 
Release of the N-glycans from the denatured proteins 
was performed by adding 1.0 µ L of PNGase F (200 
mU), and incubated at 50 °C for 20 minutes. Then, 
evaporative fluorescent labeling was performed using 
4.0 µL of 40 mM APTS in 20% acetic acid, 2.0 µ L of 
NaBH3CN (1 M in THF) and 4 µL 20% acetic acid as 
described earlier [24]. The reaction mixture was then 
incubated in a heating block with open cap at 37 °C 
overnight under fume hood. After the labeling step, the 
samples were purified by magnetic beads following the 
Fast Glycan Sample Preparation and Analysis protocol 
(SCIEX) and analyzed by CE-LIF.  
 Serum samples were collected from healthy 
volunteers. Vacutainer blood sampling tubes (filled with 
clot activator and separator gel) were from Becton, 
Dickinson and Company (Franklin Lakes, NJ, USA). 
The serum samples were collected in tubes containing 
the clot activator and the separator gel. Each sample 
was kept at room temperature for 30, 90, and 270 
minutes in order to evaluate the possible effect of 
delayed centrifugation. The control samples were 
centrifuged immediately after collection, typically within 
30 minutes. Centrifugation was performed in 2690 x g 
at 4°C for 20 minutes. After the centrifugation, samples 
were aliquoted into triplicates and stored at - 20°C until 
further processing.  
 Serum samples were processed as follows: 2 µL of 
serum was diluted with HPLC grade water to 10 µL, 
followed by temperature gradient denaturation by 
increasing the temperature with the rate of 5.0°C/min 
from 30°C to 80°C with an additional 5.0 min incubation 
step at 80°C with 5 µL denaturation solution containing 
0.375 % NP-40, 12.75% glycerol, 0.625% SDS and 
12.5 mM DTT as reported previously [25]. Release of 
the N-glycans from the denatured proteins was 
performed by adding 1.0 µL of PNGase F (200 mU) 
and 19 μL water, followed by incubation at 50°C for 60 
minutes. The samples were then cooled in ice for 1 
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minute, diluted with 70 µL of ice-cold acetonitrile in 
order to precipitate the protein content by centrifugation 
at 11.290 x g for 10 minutes. The released glycan 
containing supernatant was dried in a vacuum 
centrifuge and labeled using the evaporative labeling 
approach and purified as described above.  
2.3. Capillary electrophoresis  
 Capillary electrophoresis analyses with laser 
induced fluorescent detection (CE-LIF) (excitation:488 
nm, emission: 520 nm) were performed using a PA800 
Plus Pharmaceutical Analysis System (SCIEX). 
Separation conditions for whole blood samples: 30 cm 
total (20 cm effective) length, 50 µm i.d. bare fused 
silica capillary with HR-NCHO gel buffer (Sciex); 
Separation voltage: 30 kV (0.5 min ramp) in reversed 
polarity mode (cathode at the injection side, anode at 
the detection side); temperature: 25°C; injection: 5 
psi/5 sec water pre-injection followed by 2 kV/2 sec 
sample. Separation conditions for serum samples: 60 
cm total (50 cm effective) length, 50 µm i.d. bare fused 
silica capillary with NCHO gel buffer (Sciex); 
Separation voltage: 30 kV (0.5 min ramp) in reversed 
polarity mode; temperature: 25°C; injection: 1 psi for 5 
sec. In both cases, data acquisition and analysis were 
performed by the 32Karat (version 10.1) software 
package (SCIEX). Relative peak area percentage 
values of the separated components were calculated 
by the PeakFit v4.12 Software (SeaSolve Software 
Inc., San Jose, CA). GU value calculation and 
structural N-glycan assignment were accomplished by 
using the GUcal software and its built-in database 
(www.gucal.hu) [26]. 
3. RESULTS AND DISCUSSION 
 In this study, the effect of processing conditions on 
the global N-glycosylation profile of human blood 
samples was investigated by CE-LIF with special 
attention on the fate of sialylated structures. Recently 
reported new sample preparation protocols were 
applied to accommodate the high complexity of the 
human blood N-glycome, including temperature 
adjusted denaturation and evaporative labeling protocol 
[24, 25]. First, the global N-glycosylation profile of 
whole human blood was analyzed in as native form as 
rationally possible in order to establish a reference 
state for the consequent comparisons [26]. The most 
commonly used anticoagulant in clinical practice is 
heparin, a naturally occurring glycosaminoglycan, thus 
may cross-contaminate sensitive CE based glycan 
profiling [27, 28]. To avoid the appearance of heparin 
originated glycans in the blood N-glycan profiling, 
ethylenediamine tetraacetic acid (EDTA) was used 
instead of heparin [29]. EDTA was added to the 
collected whole blood samples and immediately 
processed in order to minimize any possible changes in 
the N-glycan composition by chemical or enzymatic 
degradation. A representative electropherogram of the 
healthy human total blood sample N-glycome is shown 
in Fig. 1. Structural elucidation of all separated N-
glycans was accomplished as reported in [30]. Briefly,  
 
structure identification utilized direct mining of GU 
database entries (GUcal application linked with the 
GlycoStore data collection), and some earlier published 
literature data on similar samples [30-32]. 
 After establishing the reference profile, the sample 
handling conditions have been studied. In clinical 
environments (among others, local medical core-facility 
laboratories and global serving testing laboratories) 
where numerous blood samples are analyzed daily, 
immediate sample processing is not always feasible, 
thus storage could not be avoided. Therefore, the effect 
of storage time and temperature on the N-glycosylation 
profile of the collected whole human blood was 
investigated. One set of sample was stored at 4°C for 
24-hour before sample processing and analysis, while 
another set was processed immediately after blood 
collection. The resulted electropherograms are 
compared using a mirror diagram shown in Fig. 2. 
Trace A depicts the CE-LIF N-glycan profile of the 
blood sample kept at room temperature for 2 hours, 
then stored at 4°C for 24-hour before sample 
processing. Trace B shows the results when the 
sample was kept at room temperature for 2 hours and 
immediately processed without any further storage. 
Peaks #1-4 correspond to variously sialylated 
structures showing only minor changes during the 24 
hour 4°C storage. It is important to note that sialylated 
structures tend to be sensitive to small environmental 
alterations [2, 33]. Peaks #5-13 revealed no apparent 
change. Peaks marked with asterisks were not 
identified but showed significant changes in the N-
glycan profile due to temperature depending 
degradation. This degradation of the sugar oligomers 
was earlier assumed to be the result of non-ATP 
mediated enzymatic reactions, which might still work 
under extracorporeal conditions [10]. The presumable 
mannose oligomers are marked with an asterisk in Fig. 
2. As a conclusion of these experiments, it seems to be 
adequate to store the collected total blood samples at 
4°C for 24 hours in order to ensure unbiased results of 
the applied sample preparation protocol and CE-LIF 
separation. In order to alleviate the reproducibility 
issues of the CE separations, peaks were normalized 
to peak 13. 
 Since immediate cooling after blood collection is 
often not possible due to practical reasons, the 
samples are kept at room temperature for a certain 
period of time. Thus, we investigated the effect of room 
temperature storage as the function of elapsed time. 
Collected samples were kept for 0, 1, 2, 3, 4, and 5 
hours at 22°C, then stored for 24 hours at 4°C before 
processing. The resulted separation traces are 
compared in Fig. 3. A thorough inspection of the traces 
suggested that up to five hours of room temperature 
storage no significant alteration occurred in the total N-
glycome profile of the whole blood sample. Most 
importantly, even the sialylated structures were not 
affected by these storage conditions, as evidenced by 
the unchanged profiles of peaks 1-5. 
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Fig. (1). Capillary electrophoresis separation of the APTS-
labeled human whole blood N-glycome. Anticoagulation of 
the collected sample was achieved by the addition of EDTA 
and the specimen was processed immediately after 
collection. Separation conditions: 30 cm total (20 cm 
effective) length, 50 µm i.d. bare fused silica capillary with 
HR-NCHO gel buffer. Voltage: 30 kV (0.5 min ramp); 
Temperature: 25°C; Injection: 5 psi/5 sec water pre-injection 
followed by 2 kV/2 sec sample. Structures corresponding to 
peaks: 1: A2G2[6]S2 2: A2BG2S2 / M3 3: FA2BG2S2 4: 
A2G2[6]S1 5: FA2G2S1 6: FA2 7: M6  8: FA2[6]G1 9: M7 10: 
FA2[3]G1 11: FA2B[6]G1 12: M8 13: FA2G2. (A higher 
resolution / colour version of this figure is available in the 
electronic copy of the article). 
 
 
Fig. (2). Capillary electrophoresis mirror diagram of the 
APTS-labeled human blood N-glycome from a blood sample 
kept at room temperature for 2 hours then stored at 4°C for 
24-hour before sample processing (A) and from a sample that 
was kept at room temperature for 2 hours then processed 
immediately (B). Separation conditions and structures were 
the same as in Fig. 1. (A higher resolution / colour version of 




Fig. (3). Comparative capillary electrophoresis analysis of the 
APTS-labeled human blood N-glycome as a function of room 
temperature storage time. The specimens were kept for (A) 0; 
(B) 1; (C) 2; (D) 3; (E) 4 and (F) 5 hours at 22 °C after blood 
taking, then stored for 24 hours at 4°C before processing. 
Separation conditions and structures corresponding to the 
separated peaks were the same as in Fig. 1. (A higher 
resolution / colour version of this figure is available in the 
electronic copy of the article). 
 
 Next, the determination of the appropriate reference 
state and its storage conditions was assessed using 
the standard procedure for total serum N-glycome 
profiling. In this stage of the study, conventionally used 
serum sample tubes were employed to explore the 
robustness of the protocol with special attention on 
conserving the sialylated structures. Serum samples 
were obtained by collecting whole blood from healthy 
volunteers in sampling tubes containing clot activator 
and separator gel (Table 1). Each sample was kept at 
room temperature for 1.5 and 4.5 hours in order to 
evaluate the possible effect of delayed centrifugation, 
which is the first step of the standard serum processing 
workflow. The control sample was centrifuged after 
collection, typically within 30 minutes, considering all 
necessary steps for serum processing after taking the 
blood sample. After centrifugation, the samples were 
stored at - 20°C until further processing. The resulted 
N-glycan profiles of the serum samples are compared 
in Fig. 4. Traces A, B and C demonstrate the effect of 
different elapsed times prior to centrifugation.  
 Please note that traces were normalized to peak 13 
in this case as well. Sialylated structures (peaks 1-5) 
were significantly decreased by 4.5 hours of storage 
time at room temperature. In addition, the ratio of peak  
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4 relative to peak 3 increased. The degradation of the 
sialic acid containing structures can be explained by 
the fact that these residues are sensitive to any minor 
changes such as storage duration and temperature. As 
one can observe in Fig. 4, non-sialylated glycan 
structures (peaks 6-13) remained stable during the 
investigated time period.  
 
 
Fig. (4). Comparative capillary electrophoresis analysis of the 
APTS-labeled human serum N-glycome. The specimens 
were kept for (A) 0.5 (control); (B) 1.5; (C) and 4.5 hour at 
room temperature after blood taking then centrifuged for 20 
min at 4°C before processing. Separation conditions: 60 cm 
total (50 cm effective) length, 50 µm i.d. bare fused silica 
capillary with NCHO gel buffer. Voltage: 30 kV (0.5 min 
ramp); Temperature: 25°C; Injection: 1 psi for 5 sec. 
Structures corresponding to peaks are the same as in Fig. 1. 
(A higher resolution / colour version of this figure is available 
in the electronic copy of the article). 
CONCLUSION 
 In this work, the effect of human blood sample 
handling was studied prior to N-glycosylation profiling 
by capillary electrophoresis coupled with high sen-
sitivity fluorescence detection. Two different 
biospecimens (total blood and serum samples) were 
studied investigating the influence of storage duration 
and temperature conditions. The total blood was 
processed utilizing recently reported new sample 
preparation protocols, including temperature adjusted 
denaturation and evaporative labeling to accomplish N-
glycome profile determination in its native form. Profile 
of the total blood was used as a reference for the 
subsequent comparative studies. In contrast, serum 
samples were analyzed using conventional workflows 
to explore the robustness of the currently applied 
techniques with special attention to conserving the 
sialylated structures. 
 Human whole blood N-glycome profile from capillary 
electrophoresis separation was reported together with 
the structural elucidation of the most significant com-
ponents using direct mining of GU database entries.  
 
Table 1. Identified N-glycan structures (nomenclature 
followed the guidelines of the Consortium of 
Functional Glycomics [34]). Entry numbers 
correspond to the peak numbers in the 
Figures. Symbols:  Sialic acid (N-
acetylneuraminic acid);   Galactose;   N-
acetylglucosamine;  Mannose; Fucose. 
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Our results of the storage condition assessment 
suggested that it was adequate to refrigerate and store 
the collected total blood samples up to 24 hours prior to 
analysis and still obtain apparently unchanged profiles. 
However, immediate cooling after blood collection is 
often not possible. Thus we investigated the effect of 
room temperature storage on the total N-glycome 
profile of the whole blood samples. No significant 
alteration was found in the total N-glycome; even the 
sialylated structures were conserved.  
 Finally, we investigated the effect of the processing 
time on the global N-glycosylation profile of human 
serum samples collected by the standard clinical 
protocol (i.e., utilization of blood sampling tubes filled 
with clot activator and separator gel). It was concluded 
that the sialylated structures were conserved up to 1.5 
hours. However, it has been demonstrated that longer 
than 1.5 hours of storage at room temperature, the 
sialylated structures started to decompose. After 4.5 
hours of storage time, the overall amount of sialylated 
structures decreased by ~50 %. As a conclusion, it is 
strongly recommended to avoid keeping the drawn 
blood samples for more than 1.5 hours at room 
temperature prior to centrifugation. It is especially 
important when samples are intended to be used for N-
glycosylation profiling including sialylated structures. 
 The reported findings demonstrated that the blood 
N-glycome is a robust target for molecular medicinal 
research provided not to be stored at room temperature 
for longer than 1.5 hours. Based on the results reported 
in this paper, we plan to carry out future studies 
involving a larger cohort of  samples from different 
patient groups for statistical purposes. 
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